Edition:
United States

Stemline Therapeutics Inc (STML.OQ)

STML.OQ on NASDAQ Stock Exchange Capital Market

6.85USD
24 Feb 2017
Change (% chg)

$0.40 (+6.20%)
Prev Close
$6.45
Open
$6.45
Day's High
$6.90
Day's Low
$6.43
Volume
35,312
Avg. Vol
80,174
52-wk High
$14.60
52-wk Low
$3.93

Select another date:

Thu, Feb 2 2017

BRIEF-Stemline Therapeutics provides update on pivotal BPDCN trial

* Stemline therapeutics provides update on pivotal bpdcn trial

BRIEF-Stemline Therapeutics reports Q3 financial results

* Stemline Therapeutics reports third quarter 2016 financial results and highlights recent regulatory and clinical progress

BRIEF-Stemline announces seven presentations

* Stemline announces seven presentations, including oral presentation of updated SL-401 phase 2 BPDCN data, at upcoming ASH meeting Source text for Eikon: Further company coverage:

Select another date:

More From Around the Web